摘要
背景:脑血管疾病和高血压在阿尔茨海默病(AD)的进展中起着至关重要的作用。然而,脑血管疾病和高血压是否通过一种独立的或相互作用的效应促进AD的进展尚不清楚。目的:探讨脑血管病与高血压相互作用对AD进展的影响。方法:对不同严重程度脑白质改变(WMCs)患者的AD病程进行回顾性纵向研究。进行年度综合心理测量学检查。WMCs采用年龄相关WMCs评定量表(ARWMC)。结果:本研究共收集散发性AD患者278例。患者平均年龄76.6}7.4岁,高血压166例。在高血压AD患者中,临床痴呆量表(CDR-SB)和CDR评分(CDR-SB:5.8比3.6,经调整P=0.0 4)均有明显的重度基线ARWMC评分(P=0.0 4);CDR:6.4 vs.4.4,调整后P=0.04)和额叶面积(CDR-SB:2.4 vs.1.2,调整P=0.01;CDR:2.4 vs.1.7,调整后P<0.01)。相反,在无高血压的AD患者中,ARWMC评分在有和没有恶化的患者之间没有显着性差异。结论:高血压患者与非高血压患者脑血管病变对AD进展的影响可能不同。高血压与WMCs相互作用而非独立影响AD的进展是可能的。
关键词: 血管紧张素转换酶插入/缺失多态性,阿尔茨海默病,脑血管病,脑白质改变,高血压,纵向研究。
Current Alzheimer Research
Title:Effect of the Interaction Between Hypertension and Cerebral White Matter Changes on the Progression of Alzheimer Disease
Volume: 15 Issue: 14
关键词: 血管紧张素转换酶插入/缺失多态性,阿尔茨海默病,脑血管病,脑白质改变,高血压,纵向研究。
摘要: Background: Cerebrovascular pathologies and hypertension could play a vital role in Alzheimer disease (AD) progression. However, whether cerebrovascular pathologies and hypertension accelerate the AD progression through an independent or interaction effect is unknown.
Objective: To investigate the effect of the interactions of cerebrovascular pathologies and hypertension on AD progression.
Method: A retrospective longitudinal study was conducted to compare AD courses in patients with different severities of cerebral White Matter Changes (WMCs) in relation to hypertension. Annual comprehensive psychometrics were performed. WMCs were rated using a rating scale for Age-related WMCs (ARWMC).
Results: In total, 278 patients with sporadic AD were enrolled in this study. The mean age of the patients was 76.6 ± 7.4 years, and 166 patients had hypertension. Among AD patients with hypertension, those with deterioration in clinical dementia rating-sum of box (CDR-SB) and CDR had significantly severe baseline ARWMC scales in total (CDR-SB: 5.8 vs. 3.6, adjusted P = 0.04; CDR: 6.4 vs. 4.4, adjusted P = 0.04) and frontal area (CDR-SB: 2.4 vs. 1.2, adjusted P = 0.01; CDR: 2.4 vs. 1.7, adjusted P < 0.01) compared with those with no deterioration in psychometrics after adjustment for confounders. By contrast, among AD patients without hypertension, no significant differences in ARWMC scales were observed between patients with and without deterioration.
Conclusion: The effect of cerebrovascular pathologies on AD progression between those with and without hypertension might differ. An interaction but not independent effect of hypertension and WMCs on the progression of AD is possible.
Export Options
About this article
Cite this article as:
Effect of the Interaction Between Hypertension and Cerebral White Matter Changes on the Progression of Alzheimer Disease, Current Alzheimer Research 2018; 15 (14) . https://dx.doi.org/10.2174/1567205015666181002141013
DOI https://dx.doi.org/10.2174/1567205015666181002141013 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Hypothesis of the Catalytic Action of Nucleic Acid on the Conversion of Prion Protein
Protein & Peptide Letters HIV-1 TAT and IMMUNE DYSREGULATION in AIDS PATHOGENESIS: a THERAPEUTIC TARGET
Current Drug Targets Brain Perfusion In Sepsis
Current Vascular Pharmacology What Can Imaging Reveal about Obesity and the Brain?
Current Alzheimer Research Age-Related Mitochondrial Alterations without Neuronal Loss in the Hippocampus of a Transgenic Model of Alzheimer's Disease
Current Alzheimer Research New Approaches in the Diagnosis of Atherosclerosis and Treatment of Cardiovascular Disease
Recent Patents on Cardiovascular Drug Discovery Relationships Between Mitochondria and Neuroinflammation: Implications for Alzheimer’s Disease
Current Topics in Medicinal Chemistry “Care-Getting”: A Conceptual Model of Marshalling Support Near the End of Life
Current Aging Science Meet Our Editorial Board Member
Current Hypertension Reviews Therapeutic Use of Agonists of the Nuclear Receptor PPARγ in Alzheimers Disease
Current Alzheimer Research Zinc-mediated Neurotransmission in Alzheimer's Disease: A Potential Role of the GPR39 in Dementia
Current Neuropharmacology Mathematical Modelling and Feature Extraction for Probing Crucial Changes Associated with Alzheimers Disease
Current Medical Imaging Extracellular Vesicles as Drug Delivery Vehicles for Rheumatoid Arthritis
Current Stem Cell Research & Therapy Recent Advances in Nanoneurology for Drug Delivery to the Brain
Current Nanoscience Molecular Mechanisms and Therapeutic Application of NSAIDs and Derived Compounds in Alzheimers Disease
Current Alzheimer Research Peptide-Mediated Cellular Delivery of Oligonucleotide-Based Therapeutics In Vitro: Quantitative Evaluation of Overall Efficacy Employing Easy to Handle Reporter Systems
Current Pharmaceutical Design Aquaporins and Glia
Current Neuropharmacology The Role of MAPK's Signaling in Mediating ApoE4-Driven Pathology In Vivo
Current Alzheimer Research Genetic Polymorphism of LDLR (rs688) is Associated with Primary Intracerebral Hemorrhage
Current Neurovascular Research Effects of 900MHz Mobile Phone Radiation on Human Thyroid Hormone Levels
Recent Patents on Biomarkers